Eventide Asset Management, LLC 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:58 pm Sale |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Eventide Asset Management, LLC | 1,032,938 2.200% |
-2,709,569 (-72.40%) |
Filing |
| 2022-02-14 11:35 am Purchase |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Eventide Asset Management, LLC | 3,742,507 9.600% |
3,742,507 (New Position) |
Filing |